InDevR

The VaxArray Polio Assay Kit is an off the shelf standardized alternative to in-house D-antigen ELISAs, improving identity and potency testing of vaccines that contain poliovirus antigen. Applicable throughout each stage of manufacturing, from bioprocess development and monitoring to release testing and ongoing stability testing. The VaxArray Polio Assay relies on the human mAbs developed by PATH for Type 1, 2, and 3 Poliovirus D-Antigen.

Custom development of multiplexed serological assay kits tailored to specific testing requirements, using various antigen panels.

A rapid alternative potency assay for influenza vaccines based on a multiplexed sandwich immunoassay using a microarray slide printed with subtype specific monoclonal antibodies for simultaneous quantification of hemagglutinin components in mono- and multi-valent influenza vaccines.

Ready-to-use test kit for multiplexed identity, quantity, and stability testing of pneumococcal vaccines, measuring up to 24 pneumococcal polysaccharide serotypes simultaneously in less than 30 minutes.

An automated, microarray-based multiplex immunoassay kit for pandemic influenza HA vaccine testing, reactive with circulating H5 strain and pre-validated with multiple A/H5 viruses to reduce analytical development burden and accelerate market path.

Multiplexed immunoassays for subtype-specific detection of seasonal and pandemic hemagglutinin (HA), seasonal neuraminidase (NA), and nucleoprotein (NP) with pre-validated capture reagents for vaccine development, manufacture, and release.

A multiplex immunoassay kit for identity and quantification of Neuraminidase (NA) N1 antigen from circulating H5N1 strain, speeding vaccine development timeline.

A kit consisting of 2 slides for coronavirus spike protein antigen testing as part of the VaxArray platform.

A versatile multivalent hemagglutinin assay kit for identity and quantity of seasonal influenza subtypes A/H1, A/H3, B/Victoria, and B/Yamagata lineages, validated for multiple production platforms including egg, cell, recombinant, and mRNA-expressed HA proteins.

A kit consisting of 2 slides for pneumococcal vaccine antigen testing as part of the VaxArray platform.

A kit consisting of 2 slides for seasonal influenza neuraminidase antigen testing as part of the VaxArray platform.

Automated hemagglutination assay reader incorporating machine learning to reduce operator time and error, standardize HAI assay interpretation, and enable regulatory compliance with digital record keeping and user permissions.

Assay kit to rapidly quantify functional spike protein in protein-based vaccines or as a functional potency test for nucleic acid vaccines.

Multiplexed assay for simplified analysis of multivalent mRNA identity and quantity in a single assay, enabling rapid vaccine or biomarker development.

An off-the-shelf assay containing multiple capture oligos specific for influenza A/H1, A/H3, B/Yamagata, and B/Victoria hemagglutinin (HA) vaccine components, designed for universal reactivity with HA mRNAs regardless of codon optimization schemes.

A ready-to-go, pre-validated, automation-friendly assay kit for quantifying hemagglutinin (HA) and neuraminidase (NA) in seasonal influenza vaccines, compatible with egg-based, cell-based, recombinant, and mRNA-expressed vaccines.

A multiplexed immunoassay kit for quantification of all three poliovirus serotypes in mono-, bi-, or trivalent vaccine samples.

Microarray assay targeting 2 influenza nucleoproteins for antigen quantification and vaccine potency testing.

An immunoassay kit for quantifying pneumococcal vaccine antigens using a microarray platform with fluorescent detection.

An off-the-shelf microarray-based assay that rapidly measures capped and intact mRNA and 5’ capping efficiency at the benchtop in less than 2 hours.

An immunoassay kit for quantifying measles and rubella antigens in vaccines with virus-specific monoclonal antibodies.